Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{fd4f7a5b709e48e9bf48ea9e97e4e6c6,
title = "Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis",
abstract = "OBJECTIVE: To investigate changes in whole-body magnetic resonance imaging (WBMRI) inflammatory and structural lesions in most joints and entheses in patients with rheumatoid arthritis (RA) treated with adalimumab.METHODS: WBMRI was obtained at weeks 0, 6, 16, and 52 in a 52 week follow-up study of 37 RA patients starting treatment with adalimumab. Readability and reliability of WBMRI were investigated for 76 peripheral joints, 23 discovertebral units, the sacroiliac joints, and 33 entheses. Changes in WBMRI joint and entheses counts were investigated.RESULTS: The readability of peripheral and axial joints was 82-100{\%}, being less for elbows and small joints of the feet. For entheses, 72-100{\%} were readable, except for entheses at the anterior chest wall, elbow, knee, and plantar fascia. The intrareader agreement was high for bone marrow oedema (BMO), bone erosion (80-100{\%}), and enthesitis (77-100{\%}), and slightly lower for synovitis and soft tissue inflammation (50-100{\%}). All synovitis, BMO, and soft tissue inflammation counts decreased numerically during treatment. The 26-joint synovitis WBMRI count decreased significantly during the first 16 weeks for patients with a good European League Against Rheumatism (EULAR) response (from median 6 to 4, p < 0.05), but not for patients with a moderate or no EULAR response. There were no overall changes in structural lesions.CONCLUSIONS: WBMRI allows simultaneous monitoring of most axial and peripheral joints and entheses in RA patients and can visualize a decrease in inflammatory counts during treatment. This first WBMRI follow-up study of patients with RA encourages further investigation of the usefulness of WBMRI in RA.",
keywords = "Adalimumab, Adult, Aged, Antirheumatic Agents, Arthritis, Rheumatoid, Bone Marrow, Cervical Vertebrae, Edema, Female, Follow-Up Studies, Foot Joints, Hand Joints, Hip Joint, Humans, Inflammation, Intervertebral Disc, Joints, Knee Joint, Lumbar Vertebrae, Magnetic Resonance Imaging, Male, Middle Aged, Reproducibility of Results, Sacroiliac Joint, Synovitis, Whole Body Imaging, Journal Article",
author = "Axelsen, {M B} and I Eshed and M {\O}stergaard and Hetland, {M L} and M{\o}ller, {J M} and Jensen, {D V} and Krintel, {S B} and Hansen, {M S} and L Terslev and M Klarlund and Poggenborg, {R P} and L Balding and Pedersen, {S J}",
note = "COPECARE",
year = "2017",
month = "7",
doi = "10.1080/03009742.2016.1231338",
language = "English",
volume = "46",
pages = "253--262",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Informa Healthcare",
number = "4",

}

RIS

TY - JOUR

T1 - Monitoring total-body inflammation and damage in joints and entheses

T2 - the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis

AU - Axelsen, M B

AU - Eshed, I

AU - Østergaard, M

AU - Hetland, M L

AU - Møller, J M

AU - Jensen, D V

AU - Krintel, S B

AU - Hansen, M S

AU - Terslev, L

AU - Klarlund, M

AU - Poggenborg, R P

AU - Balding, L

AU - Pedersen, S J

N1 - COPECARE

PY - 2017/7

Y1 - 2017/7

N2 - OBJECTIVE: To investigate changes in whole-body magnetic resonance imaging (WBMRI) inflammatory and structural lesions in most joints and entheses in patients with rheumatoid arthritis (RA) treated with adalimumab.METHODS: WBMRI was obtained at weeks 0, 6, 16, and 52 in a 52 week follow-up study of 37 RA patients starting treatment with adalimumab. Readability and reliability of WBMRI were investigated for 76 peripheral joints, 23 discovertebral units, the sacroiliac joints, and 33 entheses. Changes in WBMRI joint and entheses counts were investigated.RESULTS: The readability of peripheral and axial joints was 82-100%, being less for elbows and small joints of the feet. For entheses, 72-100% were readable, except for entheses at the anterior chest wall, elbow, knee, and plantar fascia. The intrareader agreement was high for bone marrow oedema (BMO), bone erosion (80-100%), and enthesitis (77-100%), and slightly lower for synovitis and soft tissue inflammation (50-100%). All synovitis, BMO, and soft tissue inflammation counts decreased numerically during treatment. The 26-joint synovitis WBMRI count decreased significantly during the first 16 weeks for patients with a good European League Against Rheumatism (EULAR) response (from median 6 to 4, p < 0.05), but not for patients with a moderate or no EULAR response. There were no overall changes in structural lesions.CONCLUSIONS: WBMRI allows simultaneous monitoring of most axial and peripheral joints and entheses in RA patients and can visualize a decrease in inflammatory counts during treatment. This first WBMRI follow-up study of patients with RA encourages further investigation of the usefulness of WBMRI in RA.

AB - OBJECTIVE: To investigate changes in whole-body magnetic resonance imaging (WBMRI) inflammatory and structural lesions in most joints and entheses in patients with rheumatoid arthritis (RA) treated with adalimumab.METHODS: WBMRI was obtained at weeks 0, 6, 16, and 52 in a 52 week follow-up study of 37 RA patients starting treatment with adalimumab. Readability and reliability of WBMRI were investigated for 76 peripheral joints, 23 discovertebral units, the sacroiliac joints, and 33 entheses. Changes in WBMRI joint and entheses counts were investigated.RESULTS: The readability of peripheral and axial joints was 82-100%, being less for elbows and small joints of the feet. For entheses, 72-100% were readable, except for entheses at the anterior chest wall, elbow, knee, and plantar fascia. The intrareader agreement was high for bone marrow oedema (BMO), bone erosion (80-100%), and enthesitis (77-100%), and slightly lower for synovitis and soft tissue inflammation (50-100%). All synovitis, BMO, and soft tissue inflammation counts decreased numerically during treatment. The 26-joint synovitis WBMRI count decreased significantly during the first 16 weeks for patients with a good European League Against Rheumatism (EULAR) response (from median 6 to 4, p < 0.05), but not for patients with a moderate or no EULAR response. There were no overall changes in structural lesions.CONCLUSIONS: WBMRI allows simultaneous monitoring of most axial and peripheral joints and entheses in RA patients and can visualize a decrease in inflammatory counts during treatment. This first WBMRI follow-up study of patients with RA encourages further investigation of the usefulness of WBMRI in RA.

KW - Adalimumab

KW - Adult

KW - Aged

KW - Antirheumatic Agents

KW - Arthritis, Rheumatoid

KW - Bone Marrow

KW - Cervical Vertebrae

KW - Edema

KW - Female

KW - Follow-Up Studies

KW - Foot Joints

KW - Hand Joints

KW - Hip Joint

KW - Humans

KW - Inflammation

KW - Intervertebral Disc

KW - Joints

KW - Knee Joint

KW - Lumbar Vertebrae

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Reproducibility of Results

KW - Sacroiliac Joint

KW - Synovitis

KW - Whole Body Imaging

KW - Journal Article

U2 - 10.1080/03009742.2016.1231338

DO - 10.1080/03009742.2016.1231338

M3 - Journal article

VL - 46

SP - 253

EP - 262

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 4

ER -

ID: 52654412